- Home
- RNXT vs IOBT Comparison
RNXT vs IOBT Comparison
Compare RNXT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- IOBT
- Stock Information
- Founded
- RNXT 2012
- IOBT 2014
- Country
- RNXT United States
- IOBT Denmark
- Employees
- RNXT N/A
- IOBT N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- RNXT Health Care
- IOBT Health Care
- Exchange
- RNXT Nasdaq
- IOBT Nasdaq
- Market Cap
- RNXT 44.0M
- IOBT 50.5M
- IPO Year
- RNXT 2021
- IOBT 2021
- Fundamental
- Price
- RNXT $1.11
- IOBT $1.04
- Analyst Decision
- RNXT Strong Buy
- IOBT Buy
- Analyst Count
- RNXT 2
- IOBT 4
- Target Price
- RNXT $7.50
- IOBT $3.50
- AVG Volume (30 Days)
- RNXT 552.5K
- IOBT 6.4M
- Earning Date
- RNXT 11-13-2025
- IOBT 11-07-2025
- Dividend Yield
- RNXT N/A
- IOBT N/A
- EPS Growth
- RNXT N/A
- IOBT N/A
- EPS
- RNXT N/A
- IOBT N/A
- Revenue
- RNXT $662,000.00
- IOBT N/A
- Revenue This Year
- RNXT $2,895.35
- IOBT N/A
- Revenue Next Year
- RNXT $313.04
- IOBT N/A
- P/E Ratio
- RNXT N/A
- IOBT N/A
- Revenue Growth
- RNXT N/A
- IOBT N/A
- 52 Week Low
- RNXT $0.75
- IOBT $0.32
- 52 Week High
- RNXT $1.69
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- RNXT 46.69
- IOBT 54.21
- Support Level
- RNXT $0.98
- IOBT $0.79
- Resistance Level
- RNXT $1.15
- IOBT $1.23
- Average True Range (ATR)
- RNXT 0.09
- IOBT 0.15
- MACD
- RNXT -0.01
- IOBT 0.05
- Stochastic Oscillator
- RNXT 39.99
- IOBT 72.05
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.